These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7523494)

  • 1. Characterization of soluble CD44 in the circulation of mice. Levels are affected by immune activity and tumor growth.
    Katoh S; McCarthy JB; Kincade PW
    J Immunol; 1994 Oct; 153(8):3440-9. PubMed ID: 7523494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of CD44 cytoplasmic domain in hyaluronan binding.
    Perschl A; Lesley J; English N; Trowbridge I; Hyman R
    Eur J Immunol; 1995 Feb; 25(2):495-501. PubMed ID: 7533087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding and degradation of hyaluronan by human breast cancer cell lines expressing different forms of CD44: correlation with invasive potential.
    Culty M; Shizari M; Thompson EW; Underhill CB
    J Cell Physiol; 1994 Aug; 160(2):275-86. PubMed ID: 7518822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells.
    Welsh CF; Zhu D; Bourguignon LY
    J Cell Physiol; 1995 Sep; 164(3):605-12. PubMed ID: 7544357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of human CD44H and CD44E isoform binding to hyaluronan by phorbol myristate acetate and anti-CD44 monoclonal and polyclonal antibodies.
    Liao HX; Levesque MC; Patton K; Bergamo B; Jones D; Moody MA; Telen MJ; Haynes BF
    J Immunol; 1993 Dec; 151(11):6490-9. PubMed ID: 7504022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyaluronan receptors are expressed on human malignant mesothelioma cells but not on normal mesothelial cells.
    Asplund T; Heldin P
    Cancer Res; 1994 Aug; 54(16):4516-23. PubMed ID: 7519123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble CD44 inhibits melanoma tumor growth by blocking cell surface CD44 binding to hyaluronic acid.
    Ahrens T; Sleeman JP; Schempp CM; Howells N; Hofmann M; Ponta H; Herrlich P; Simon JC
    Oncogene; 2001 Jun; 20(26):3399-408. PubMed ID: 11423990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional hyaluronan receptors are expressed on a squamous cell lung carcinoma cell line but not on other lung carcinoma cell lines.
    Teder P; Bergh J; Heldin P
    Cancer Res; 1995 Sep; 55(17):3908-14. PubMed ID: 7543820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyaluronan binding by CD44 is regulated by a phosphorylation-independent mechanism.
    Uff CR; Neame SJ; Isacke CM
    Eur J Immunol; 1995 Jul; 25(7):1883-7. PubMed ID: 7542594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymph node (but not spleen) invasion by murine lymphoma is both CD44- and hyaluronate-dependent.
    Zahalka MA; Okon E; Gosslar U; Holzmann B; Naor D
    J Immunol; 1995 May; 154(10):5345-55. PubMed ID: 7537306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Origin and function of circulating CD44 in non-Hodgkin's lymphoma.
    Ristämaki R; Joensuu H; Grön-Virta K; Salmi M; Jalkanen S
    J Immunol; 1997 Mar; 158(6):3000-8. PubMed ID: 9058839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody.
    Guo Y; Ma J; Wang J; Che X; Narula J; Bigby M; Wu M; Sy MS
    Cancer Res; 1994 Mar; 54(6):1561-5. PubMed ID: 7511044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shedding of the CD44 adhesion molecule from leukocytes induced by anti-CD44 monoclonal antibody simulating the effect of a natural receptor ligand.
    Bazil V; Horejsí V
    J Immunol; 1992 Aug; 149(3):747-53. PubMed ID: 1634766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for presence of hyaluronan binding protein on spermatozoa and its possible involvement in sperm function.
    Ranganathan S; Ganguly AK; Datta K
    Mol Reprod Dev; 1994 May; 38(1):69-76. PubMed ID: 7519432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruption of T lymphocyte reappearance in anti-Thy-1-treated animals in vivo with soluble CD44 and L-selectin molecules.
    Guo YJ; Wong JH; Lin SC; Aruffo A; Stamenkovic I; Sy MS
    Cell Immunol; 1994 Mar; 154(1):202-18. PubMed ID: 7509728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adhesion molecules on intermediate TCR cells. I. Unique expression of adhesion molecules, CD44+ L-selectin-, on intermediate TCR cells in the liver and the modulation of their adhesion by hyaluronic acid.
    Arai K; Iiai T; Nakayama M; Hasegawa K; Sato K; Ohtsuka K; Watanabe H; Hanyu T; Takahashi HE; Abo T
    Immunology; 1995 Jan; 84(1):64-71. PubMed ID: 7534265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycosylation of CD44 negatively regulates its recognition of hyaluronan.
    Katoh S; Zheng Z; Oritani K; Shimozato T; Kincade PW
    J Exp Med; 1995 Aug; 182(2):419-29. PubMed ID: 7543137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of CD44 in the development of natural killer cells from precursors in long-term cultures of mouse bone marrow.
    Delfino DV; Patrene KD; DeLeo AB; DeLeo R; Herberman RB; Boggs SS
    J Immunol; 1994 Jun; 152(11):5171-9. PubMed ID: 7514628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a novel heparin binding domain in RHAMM and evidence that it modifies HA mediated locomotion of ras-transformed cells.
    Yang B; Hall CL; Yang BL; Savani RC; Turley EA
    J Cell Biochem; 1994 Dec; 56(4):455-68. PubMed ID: 7534313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trafficking of CD44-deficient murine lymphocytes under normal and inflammatory conditions.
    Stoop R; Gál I; Glant TT; McNeish JD; Mikecz K
    Eur J Immunol; 2002 Sep; 32(9):2532-42. PubMed ID: 12207337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.